Graphene-based nanomaterials are gaining increasing attention mainly due to their applications in biotechnology, biomedicine, bioengineering, disease diagnosis and therapy. In fact, the intensive utilisation of graphene and other two-dimensional (2D) nanomaterials has also increased the need for an assessment of their impact on the environment and health. Therefore, the EU-funded ACCORDs project will develop an imaging-based characterisation framework for the holistic correlative assessment of graphene family materials (GFMs) as a representative of 2D nanomaterials. ACCORDs will translate principles of medical imaging-based diagnostics to 2D material hazard diagnostics. It will accelerate industrial sectors in the area of aviation, marine construction, drone production, flexible electronics, photovoltaics, photocatalytics and print inks-based sensors.
1 January 2023 – 30 June 2026